多祖先全基因组关联帕金森病的元分析
Jonggeol Jeffrey Kim1,2, Dan Vitale3,4,5, Diego Véliz Otani6,7
1Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. kimjoj@nih.gov.
Nature genetics
|December 28, 2023
概括
这项研究确定了78名帕金森氏症患者.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 神经退行性疾病 神经退行性疾病
背景情况:
- 已知有超过90种帕金森病 (PD) 风险变体,但大多数遗传研究都集中在单个人群上.
- 这限制了研究结果的概括性和对跨不同祖先的PD遗传结构的理解.
研究的目的:
- 为了对帕金森病进行大规模,多祖先的元分析.
- 为了确定新的遗传风险位点和精细地图病因变异的PD跨多种人群.
主要方法:
- 进行了全基因组关联研究 (GWAS) 的元分析,包括超过49000例PD病例和240万对照.
- 包括来自欧洲,东亚,拉丁美洲和非洲祖先的个人.
- 综合结果与公开可用的表达量特征位置 (eQTL) 数据.
主要成果:
- 鉴定出78个独立的全基因组显著位置与帕金森病相关.
- 在已知的PD位点发现了12个潜在的新位点,并精确地绘制了6个假定的因果变异.
- 通过基因表达,在新的位点中确定了25个假定风险基因,与PD风险相关.
结论:
- 这种多祖先元分析显著扩大了帕金森病已知的遗传景观.
- 这些发现为未来对PD遗传学的研究提供了基础,特别是在代表性不足的人群中.
- 确定了新的风险基因和变异,有助于帕金森病易感性.
更多相关视频
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
6.0K
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
14.9K
相关概念视频
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Parkinson's Disease: Overview
553
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
553
Parkinson's Disease: Treatment
273
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
273
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
